Additionally, it was noted that the overexpression of hsa-miR-34a-5p may mitigate the resistance of GC cells to multiple drugs by decreasing the expression of SIRT1, P-gp, or MRP1 [130]. The gene discussed is PGP; the disease is gastric cancer.